FDA Expands Approval of Concizumab-mtci to Include Hemophilia A, B Without Inhibitor Use
The approval builds upon concizumab’s previous December 2024 clearance and allows for treatment in patients with hemophilia A or B,…
Study: Exposure to Trihalomethane Concentrations Increases CKD Risk
The authors note that the findings can have significant public health implications given the widespread water chlorination and increased chronic…
Barriers to Accessing TKIs in CML
A panelist discusses how accessing tyrosine kinase inhibitors for chronic myeloid leukemia treatment faces multiple barriers including financial challenges from…
SAR446523 Granted Orphan Drug Designation for Patients With Relapsed, Refractory Multiple Myeloma
Sanofi’s SAR446523 receives orphan drug designation for relapsed refractory multiple myeloma, enhancing treatment options and patient outcomes.
Weight Loss Drugs Show Promise in Preventing Stroke and Reducing Brain Injury Complications
New research reveals that GLP-1 receptor agonists like semaglutide may significantly reduce stroke impacts and improve recovery outcomes.
Researchers Assess Cardiovascular Outcomes in Older Adults Hospitalized with Respiratory Syncytial Virus
RSV hospitalization in older adults links to increased cardiovascular events, highlighting the need for vigilant monitoring and vaccination strategies.
Baxdrostat Reduces Systolic Blood Pressure in Uncontrolled, Treatment-Resistant Hypertension
By targeting aldosterone in a 2-dose regimen, baxdrostat effectively lowers mean seated systolic blood pressure in patients with difficult-to-treat hypertension.
Pirtobrutinib Outperforms Ibrutinib in Head-to-Head Phase 3 Trial for CLL/SLL
Pirtobrutinib shows promising results in a head-to-head trial against ibrutinib for chronic lymphocytic leukemia (CLL)/small lymphocytic leukemia (SLL).
Biosimilar Mvasi Demonstrates Similar Ophthalmic Safety Profile to Reference Product Avastin
A recent study reveals Mvasi’s comparable safety profile to Avastin for retinal diseases, highlighting the need for on-label biosimilars in…